Wexford Capital

Dig Inn is a restaurant inspired by the seasons and the act of cooking. Classic recipes with lots of vegetables, expertly prepared, and sourced mindfully from farmers and producers we know and trust. Whether you’re looking for whole grains, naturally-raised meats, or fresh veggies, we’ve got a bowl with your name on it.

Bonterra Resources Inc., an exploration stage company, engages in the acquisition, exploration, and evaluation of natural resource properties in Canada. It explores primarily for gold deposits. The Company’s projects include the Gladiator Deposit, the Moroy Deposit and Bonterra Mill, and the Barry Deposit located in the provinces of Quebec, Canada. Bonterra Resources Inc. was incorporated in 2007 and is headquartered in Val-d’Or, Canada.

NxtPhase develops, manufactures, and markets optical sensor and digital solutions for the electric power industry. The company’s products include optical current and voltage sensors; and opto-electronic modules that provide signal processing electronics for voltage and current transducers. NxtPhase was founded in 1993 and is headquartered in Vancouver, Canada.

Javelin Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products for the pain management market primarily in the United States and Europe. Its products focus on treating various pain disorders ranging from acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post-operative pain, post-trauma pain (orthopedic injury pain), procedural pain, and burn pain. The company's Dyloject (injectable diclofenac) received approval for marketing to treat post-operative pain in the United Kingdom and was licensed to Therabel Pharma N.V. for commercialization in the European Union and certain other countries outside the United States. Its products in the Phase 3 development stage in the U.S. include Dyloject (diclofenac sodium injectable), an injectable formulation of diclofenac and a prescription nonsteroidal anti-inflammatory drug that is used to treat post-operative pain due to its combination of effectiveness and tolerability; Ereska (intranasal ketamine), a proprietary nasal formulation; and Rylomine (intranasal morphine) for treatment of acute moderate-to-severe pain, including breakthrough pain. Javelin Pharmaceuticals has license agreements with Shimoda Biotech, Ltd. to develop and commercialize products related to a proprietary formulation of the injectable delivery of diclofenac; and West Pharmaceutical Services, Inc. to develop and commercialize intranasal morphine for the transmucosal delivery of morphine to humans and animals for the treatment of pain. The company was founded in 1998 and is based in Cambridge, Massachusetts.

Shape Memory Therapeutics, Inc., a medical device company, focuses on the commercialization of medical devices based on shape memory polymer materials for minimally invasive (endovascular) applications. The company was founded in 2009 and is based in College Station, Texas.

Reverse Medical is a commercial-stage medical device company focused on revascularizing patients experiencing Acute Ischemic Stroke.

Tigris Pharmaceuticals, Inc., a biopharmaceutical company, develops therapeutic technologies for oncology and other areas of unmet medical need. Its products include Aminoflavone that is for the treatment of renal cell, breast, and lung cancer; GGTI-2418, a synthetic peptidomimetic inhibitor of geranylgeranyltransferase, which is for the treatment of lung, breast, pancreatic, and ovarian cancer; GFB-204, a calixarene derivative that is a potent and selective inhibitor of VEGFR and PDGFR tyrosine phosphorylation, which is for the treatment of prostate, pancreas, lung, breast, and renal cell. The company was founded in 2005 and is based in Bonita Springs, Florida.

Viseon, Inc. operates as a medical device company. It has developed the Voyant technology for use in both posterior and lateral access MIS spine procedures. The company’s technology offers a single-use disposable alternative to surgical microscopes, endoscopes and loupes, projecting the operative field onto a high definition flat panel display within the OR and to remote locations. Viseon, Inc. was incorporated in 2017 and is based in Irvine, California.

Invuity, Inc. develops visualization products for the less invasive surgical field applications. It offers BriteField Port System that provides illumination and visualization during minimally invasive procedures; and BriteField McCulloch retractor, which allows physicians to achieve visualization during surgery while using traditional techniques. Invuity, Inc. was formerly known as Spotlight Surgical Inc. The company was founded in 2004 and is headquartered in San Francisco, California.

ElMindA vision is to bring a paradigm change to the management of brain disorders and injuries, by transforming state of the art neuroscience into bed-side clinical practice. ElMindA has developed the BNA™ technology platform, which for the first time allows high resolution visualization and evaluation of the complex neuro-physiological interconnections of the human brain at work, capturing information on the composition, connectivity, synchronization and operation of brain networks.

Sophono, Inc. develops and manufactures magnetic bone conduction hearing devices for patients with conductive hearing loss, mixed hearing loss, and single-sided deafness worldwide. It offers Alpha 2 MPO, a bone conduction hearing device that brings abutment-free bone conduction for the patients that lies under the skin. The company sells its products through clinics. The company was founded in 2009 and is based in Boulder, Colorado. As of March 26, 2015, Sophono, Inc. operates as a subsidiary of Medtronic plc.

Specialty Renal Products, a subsidiary of Nephros, is focused on the development of medical device products for patients with renal disease, including a hemodiafiltration system for the treatment of patients with ESRD.SRP intends to develop and market a filtration system for use in conjunction with the disposable tubing circuit sets used in treatments that provide continuous renal replacement therapy (CRRT). The system will apply to patients who present in the intensive care unit with acute kidney injury (AKI). CRRT allows the clinician the ability to manage unstable AKI patients by offering slower ultrafiltration and solute removal. Some advantages with performing CRRT continuously (24 hours per day) include improved hemodynamic tolerance and more control over the total volumes given and removed from unstable AKI patients.

As the vanguard of distributed energy control, Encorp leverages the power of its advanced Gold Box™ to harness diverse forms of generation in today's New Energy Economy. Their energy-tech offerings and grid interconnection expertise advance energy savings, security and efficiency for federal, institutional and commercial installations. Their technologies transform the electric grid into a system that is cleaner, more cost effective, efficient, flexible, reliable, resilient and responsive. Encorp's elegant software and hardware seamlessly integrate a variety of distributed power resources, such as engine-generator sets, microturbines, fuel cells, combined heat and power (CHP or cogeneration), and energy storage devices. These power resources are critical in the operation of any enterprise that demands high-quality, reliable power at reasonable and predictable costs.

International Battery (IB) is a green technology company providing environmentally friendly, large format, rechargeable lithium-ion cells and batteries – designed, developed and manufactured in the USA. IB provides next generation cell chemistries, electronics and advanced packaging technologies, broad design experience, and offers total solutions for rechargeable battery applications. There batteries can be used in a wide range of vehicular, industrial and military applications.

Epiphany Biosciences is developing both therapeutic products and diagnostic technologies that treat or prevent the spread of pathogenic viruses. Epiphany Biosciences is a privately-held company located in San Francisco, CA. To support its mission, Epiphany has assembled a world-class team of virologists, clinicians, and drug development experts with extensive pharmaceutical business experience to lead the company forward.

AZTherapies, Inc., a biopharmaceutical company, discovers, develops, and commercializes products for the treatment of Alzheimer’s, stroke, ALS, and Parkinson’s diseases. It develops small molecule drugs that block the triggers of dementia, which interferes with the formation of disease-causing aggregates of amyloid-beta protein oligomers and amyloid plaques. AZTherapies, Inc. was founded in 2011 and is based in Boston, Massachusetts.

Rebound has progressed rapidly over the past 18 months, having developed a unique array of devices to improve the procedural and clinical outcomes of many minimally invasive surgical procedures. In addition to rapid product development of its initial products, Rebound has assembled a world-class Scientific Advisory Board of leading MIS physicians, filed 14 patents to solidify its intellectual property platform and completed a series of pre-clinical studies supporting initial human-use, scheduled to begin soon.

Vantage Sports, Inc. provides data and video analytics platform that uses data–gathering engines that produce in-depth look at a players’ performance. It offers sports content to enterprises, media, and fans. The company was incorporated in 2011 and is based in Bellevue, Washington. Vantage Sports, Inc. operates as a subsidiary of Competitive Analytics Consulting LLC.

GlobeImmune, operates as a biopharmaceutical company. It engages in developing and manufacturing Tarmogens, a targeted molecular immunotherapy for the treatment of cancer and infectious diseases. Its products include GI-3000, a Tarmogen for epidermal growth factor receptor over expressing tumors; GI-4000, a Tarmogen for mutated-Ras mediated cancers; GI-5005, a Tarmogen for chronic hepatitis C infection; GI-8000, a Tarmogen for influenza; and GI-10000 Targeted Ablation of Mutational Escape, a novel use of the Tarmogen platform that eliminates or prevents the emergence of mutated escape variants in patients receiving antiviral or targeted cancer therapies. GlobeImmune was founded in 1995 as Ceres Pharmaceuticals, Inc. The company is based in Louisville, Colorado.

Invuity, Inc. develops visualization products for the less invasive surgical field applications. It offers BriteField Port System that provides illumination and visualization during minimally invasive procedures; and BriteField McCulloch retractor, which allows physicians to achieve visualization during surgery while using traditional techniques. Invuity, Inc. was formerly known as Spotlight Surgical Inc. The company was founded in 2004 and is headquartered in San Francisco, California.

Ellipse Technologies is focused on developing its implantable remote control technology platforms to include innovative treatments for a broad spectrum of spinal and orthopedic deformity applications, orthopedic trauma and fracture management. The initial products restore proper anatomic position and alignment of the spine and long-bones. MAGECâ„¢ MAGnetic Expansion Control System utilizes a novel motion-preserving, minimally-invasive technology that, through communication with an external magnetic field, can be non-invasively adjusted in an outpatient setting via remote control by the physician to correct spinal deformities. PRECICE System uses non-invasive adjustable intramedullary rods or bone plates to treat long-bone abnormalities, often the result of acute or chronic fractures. Ellipse is a privately-held medical device company located in California.

Viseon, Inc. operates as a medical device company. It has developed the Voyant technology for use in both posterior and lateral access MIS spine procedures. The company’s technology offers a single-use disposable alternative to surgical microscopes, endoscopes and loupes, projecting the operative field onto a high definition flat panel display within the OR and to remote locations. Viseon, Inc. was incorporated in 2017 and is based in Irvine, California.

Infinia Corporation is a solar energy technology company and the developer of the PowerDish, a proprietary solar power generation product that converts solar energy into electricity. The PowerDish is expected to be sold globally beginning in late 2010 and will be initially sold to energy asset developers, utilities, commercial companies and others engaged in deploying large scale solar asset projects.

OptiScan Biomedical Corporation develops glucose monitoring systems for the intensive care unit (ICU)/CCU. It offers OptiScanner, an automated, bedside glucose monitoring system to assist healthcare providers manage the glucose level of critically ill patients. The company’s OptiScanner provides serial blood glucose measurements for a range of glucose concentrations. OptiScan Biomedical Corporation was founded in 1994 and is based in Hayward, California.

Interventional Spine, Inc. engages in the design, development, production, and distribution of implantable devices for the spine to patients, surgeons, and hospitals worldwide. It offers Opticage expandable interbody fusion device; and PERPOS PLS System compressible facet fixation system. The company provides devices for podiatric and orthopedic trauma markets; and sells its products through a network of distributors. The company was formerly known as Triage Medical, Inc. and changed its name to Interventional Spine, Inc. in November 2006. Interventional Spine, Inc. was founded in 2000 and is based in Irvine, California. As of January 3, 2017, Interventional Spine, Inc. operates as a subsidiary of DePuy Synthes, Inc.

ICx Technologies is a leader in the development and integration of advanced sensor technologies for homeland security, force protection and commercial applications. Their proprietary sensors detect and identify chemical, biological, radiological, nuclear and explosive threats, and deliver superior awareness and actionable intelligence for wide-area surveillance, intrusion detection and facility security. They then leverage their unparalleled technical expertise and government funding to address other emerging challenges of their time ranging from a cleaner environment, alternative energy to life science.

Infinia Corporation is a solar energy technology company and the developer of the PowerDish, a proprietary solar power generation product that converts solar energy into electricity. The PowerDish is expected to be sold globally beginning in late 2010 and will be initially sold to energy asset developers, utilities, commercial companies and others engaged in deploying large scale solar asset projects.